Oncology Research Open Access Editors-in-Chief: Edward Chu, Enrico Mini
Home Oncology Research All Issues Volume 33 Issue 11
Volume 33 Issue 11, October 2025
PP. 3161-3609
|
22 articles
Review
Review | Open Access
Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions
Published: 22 October 2025
2025, 33(11): 3161-3183
Review | Open Access
Immune Checkpoint Inhibitors in Gastrointestinal Cancers: Current Evidence and Future Directions
Published: 22 October 2025
2025, 33(11): 3185-3206
Review | Open Access
Exosomal Non-Coding RNAs in Pancreatic Cancer: From Mechanisms to Clinical Applications
Published: 22 October 2025
2025, 33(11): 3207-3229
Review | Open Access
The Role of UFMylation in the Development and Progression of Gastric Cancer
Published: 22 October 2025
2025, 33(11): 3231-3245
Review | Open Access
Novel Strategies against Hepatocellular Carcinoma through Lipid Metabolism
Published: 22 October 2025
2025, 33(11): 3247-3268
Review | Open Access
Reprogramming the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma: Therapeutic Targets and Innovations
Published: 22 October 2025
2025, 33(11): 3269-3292
Review | Open Access
RNA Expression Signatures in Glioblastoma: A Systematic Review of Tumour Biology and Therapeutic Targets
Published: 22 October 2025
2025, 33(11): 3293-3325
Review | Open Access
Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs
Published: 22 October 2025
2025, 33(11): 3327-3346
Review | Open Access
Universal CAR-T Cell Therapy for Cancer Treatment: Advances and Challenges
Published: 22 October 2025
2025, 33(11): 3347-3373
Commentary
Commentary | Open Access
CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge
Published: 22 October 2025
2025, 33(11): 3375-3385
Article
Article | Open Access
Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy: Multicenter, Observational Study
Published: 22 October 2025
2025, 33(11): 3405-3416
Article | Open Access
Diverse PD-1, CD163, and FOXP3 Profiles in Primary and Metastatic Microenvironments of Prostate Cancer
Published: 22 October 2025
2025, 33(11): 3417-3428
Article | Open Access
Investigation on the Anti-Cancer Effects of HER2-Targeted CAR-T Cells Engineered Using the PiggyBac Transposon System
Published: 22 October 2025
2025, 33(11): 3447-3467
Article | Open Access
A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature
Published: 22 October 2025
2025, 33(11): 3469-3492
Article | Open Access
Construction of a Prognostic Model of Prostate Cancer Based on Immune and Metabolic Genes and Experimental Validation of the Gene AK5
Published: 22 October 2025
2025, 33(11): 3493-3522
Article | Open Access
RAD23B Promotes Colorectal Cancer Metastasis via the Talin1/Integrin/PI3K/AKT/MMP9 Axis
Published: 22 October 2025
2025, 33(11): 3523-3541
Article | Open Access
Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway
Published: 22 October 2025
2025, 33(11): 3543-3556
Article | Open Access
Multi-Omics Insights into the Impact of MDH2 on Breast Cancer Progression: A Promising Druggable Target
Published: 22 October 2025
2025, 33(11): 3557-3582
Article | Open Access
MINDY1 Induces PD-L1 Deubiquitination to Promote Immune Escape in Hepatocellular Carcinoma by the Wnt/β-Catenin Pathway
Published: 22 October 2025
2025, 33(11): 3583-3603
Retraction
Retraction | Open Access
Retraction: CSTB Downregulation Promotes Cell Proliferation and Migration and Suppresses Apoptosis in Gastric Cancer SGC-7901 Cell Line
Published: 22 October 2025
2025, 33(11): 3605
Retraction | Open Access
Retraction: MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1
Published: 22 October 2025
2025, 33(11): 3607
Retraction | Open Access
Retraction: Overexpression of miR-1283 Inhibits Cell Proliferation and Invasion of Glioma Cells by Targeting ATF4
Published: 22 October 2025
2025, 33(11): 3609